Novartis announced today that Prexige? (lumiracoxib), an oral selective COX-2 inhibitor anti-inflammatory drug, has been cleared for approval in the European Union as a new treatment option for patients suffering from osteoarthritis. This is the most common form of arthritis and a leading cause of chronic pain[2].
Novartis announced plans to build an integrated biomedical Research & Development center in Shanghai’s Zhangjiang Hi-Tech Park that will become an integral part of the Group’s global research and development network.
Three-quarters of those with employment-based health benefits state they would prefer $6,700 in employment-based coverage to an additional $6,700 in taxable income (75 percent).
Offering free school breakfasts to all elementary school students regardless of income increases the likelihood that the children will consume a nutritionally sound breakfast, according to researchers at the U.S. Department of Agriculture and Abt Associates, Inc.
Civil wars have replaced interstate wars as the dominant form of violence in the world and have caused over 16 million deaths since 1945, affecting every region of the planet. A new study, published in International Studies Quarterly, demonstrably shows how an investment in education decreases the likelihood of civil war in any region.
The social and economic needs of families with a disabled child are high, but remain largely unmet, argue researchers in this week’s BMJ.More disabled children and young people live in the UK than ever before (about 770,000 according to criteria defined in the Disability Discrimination Act) and the number of children with the most severe or complex needs is also increasing, write social policy experts from the University of York.
Huge amounts of money – up to $50 billion – are spent every year on pharmaceutical products, a market so large that it is extremely vulnerable to corruption. Recent estimates have shown that as much as 25% of medicines which are procured can be lost to fraud, bribery and other corrupt practices.
The State Children’s Health Insurance Program (SCHIP) has reduced the number of uninsured children in the U.S., while improving access and utilization of health care services.
Traffic at the Cognis Nutrition & Health booth at the SupplySide West trade show is expected to be brisk as dietary supplement and functional food manufacturers discover the benefits of three new, non-GMO natural health ingredients Cognis is launching — Covi-ox? T-95 EU natural mixed tocopherols, Vegapure? F40 WDP E water dispersible natural plant sterols, Xangold? 20% natural lutein ester beadlets.
CLA may serve critical role in preventing weight and fat gain during year-end holidays and with normal aging. Avoiding ‘weight creep’ from turkey and sugar plums is the theme of a consumer PR campaign Cognis Nutrition & Health is rolling out in time for the holiday season based on a Tonalin? CLA study recently published online in the prestigious International Journal of Obesity. The research suggests that Tonalin? CLA could have long-term health benefits by preventing weight and fat gain commonly experienced by adults during the November-December holiday season, and in the normal aging process.